|
1
|
Marioni G, Marchese-Ragona R, Cartei G,
Marchese F and Staffieri A: Current opinion in diagnosis and
treatment of laryngeal carcinoma. Cancer Treat Rev. 32:504–515.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Papadas TA, Alexopoulos EC, Mallis A,
Jelastopulu E, Mastronikolis NS and Goumas P: Survival after
laryngectomy: a review of 133 patients with laryngeal carcinoma.
Eur Arch Otorhinolaryngol. 267:1095–1101. 2010. View Article : Google Scholar
|
|
3
|
Moubayed SP, Bélair M, Saliba J, et al:
Prognostic value of cartilage sclerosis in laryngeal cancer treated
with primary radiation therapy. Otolaryngol Head Neck Surg.
147:57–62. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taki S, Homma A, Suzuki F, et al: Combined
modality therapy for laryngeal cancer with superselective
intra-arterial cisplatin infusion and concomitant radiotherapy. Int
J Clin Oncol. 17:441–446. 2012. View Article : Google Scholar
|
|
5
|
Agra IM, Ferlito A, Takes RP, et al:
Diagnosis and treatment of recurrent laryngeal cancer following
initial nonsurgical therapy. Head Neck. 34:727–735. 2012.
View Article : Google Scholar
|
|
6
|
Chai LP, Wang ZF, Liang WY, et al: In
vitro and in vivo effect of 5-FC combined gene therapy with TNF-α
and CD suicide gene on human laryngeal carcinoma cell line Hep-2.
PLoS One. 8:e611362013. View Article : Google Scholar
|
|
7
|
Trzcieniecka-Green A, Bargiel-Matusiewicz
K and Borczyk J: Quality of life of patients after laryngectomy. J
Physiol Pharmacol. 58(Suppl 5): S699–S704. 2007.
|
|
8
|
Yoda Y and Abe T: Fibrinopeptide A (FPA)
level and fibrinogen kinetics in patients with malignant disease.
Thromb Haemost. 46:706–709. 1981.PubMed/NCBI
|
|
9
|
Green D and Karpatkin S: Role of thrombin
as a tumor growth factor. Cell Cycle. 9:656–661. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo RR, Liu Y, Lu WL, et al: A recombinant
peptide, hirudin, potentiates the inhibitory effects of stealthy
liposomal vinblastine on the growth and metastasis of melanoma.
Biol Pharm Bull. 31:696–702. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu L, Lee M, Campbell W, Perez-Soler R and
Karpatkin S: Role of endogenous thrombin in tumor implantation,
seeding, and spontaneous metastasis. Blood. 104:2746–2751. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Caunt M, Huang YQ, Brooks PC and Karpatkin
S: Thrombin induces neoangiogenesis in the chick chorioallantoic
membrane. J Thromb Haemost. 1:2097–2102. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu M, Scanlon CS, Banerjee R, et al: The
histone methyl-transferase EZH2 mediates tumor progression on the
chick chorioallantoic membrane assay, a novel model of head and
neck squamous cell carcinoma. Transl Oncol. 6:273–281. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mackler NJ and Pienta KJ: Drug insight:
Use of docetaxel in prostate and urothelial cancers. Nat Clin Pract
Urol. 2:92–100. 2005. View Article : Google Scholar
|
|
15
|
Zhang H, Yang D, Wang H, et al:
Metastasis-associated gene 1 promotes invasion and migration
potential of laryngeal squamous cell carcinoma cells. Oncol Lett.
7:399–404. 2014.PubMed/NCBI
|
|
16
|
Ren J, Zhu D, Liu M, Sun Y and Tian L:
Downregulation of miR-21 modulates Ras expression to promote
apoptosis and suppress invasion of Laryngeal squamous cell
carcinoma. Eur J Cancer. 46:3409–3416. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo S, Colbert LS, Fuller M, Zhang Y and
Gonzalez-Perez RR: Vascular endothelial growth factor receptor-2 in
breast cancer. Biochim Biophys Acta. 1806:108–121. 2010.PubMed/NCBI
|
|
19
|
Dias S, Choy M, Alitalo K and Rafii S:
Vascular endothelial growth factor (VEGF)-C signaling through FLT-4
(VEGFR-3) mediates leukemic cell proliferation, survival, and
resistance to chemotherapy. Blood. 99:2179–2184. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dias S, Hattori K, Zhu Z, et al: Autocrine
stimulation of VEGFR-2 activates human leukemic cell growth and
migration. J Clin Invest. 106:511–521. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tavora B, Batista S, Reynolds LE, et al:
Endothelial FAK is required for tumour angiogenesis. EMBO Mol Med.
2:516–528. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gabarra-Niecko V, Schaller MD and Dunty
JM: FAK regulates biological processes important for the
pathogenesis of cancer. Cancer Metastasis Rev. 22:359–374. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Even-Ram S, Uziely B, Cohen P, et al:
Thrombin receptor over-expression in malignant and physiological
invasion processes. Nat Med. 4:909–914. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shi X, Gangadharan B, Brass LF, Ruf W and
Mueller BM: Protease-activated receptors (PAR1 and PAR2) contribute
to tumor cell motility and metastasis. Mol Cancer Res. 2:395–402.
2004.PubMed/NCBI
|
|
25
|
Kaufmann R, Schafberg H, Rudroff C and
Nowak G: Thrombin receptor activation results in calcium signaling
and protein kinase C-dependent stimulation of DNA synthesis in
HEp-2g laryngeal carcinoma cells. Cancer. 80:2068–2074. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang S, Yang Y, Liang Z, et al:
Silybin-mediated inhibition of Notch signaling exerts antitumor
activity in human hepatocellular carcinoma cells. PLoS One.
8:e836992013. View Article : Google Scholar
|
|
27
|
Jaganathan R, Ravinayagam V, Panchanadham
S and Palanivelu S: Potential therapeutic role of Tridham in human
hepatocellular carcinoma cell line through induction of p53
independent apoptosis. BMC Complement Altern Med. 13:3232013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nguyen KC, Willmore WG and Tayabali AF:
Cadmium telluride quantum dots cause oxidative stress leading to
extrinsic and intrinsic apoptosis in hepatocellular carcinoma HepG2
cells. Toxicology. 306:114–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thanapprapasr D, Hu W, Sood AK and Coleman
RL: Moving beyond VEGF for anti-angiogenesis strategies in
gynecologic cancer. Curr Pharm Des. 18:2713–2719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ludwig HC, Akhavan-Shigari R, Rausch S, et
al: Expression of focal adhesion kinase (p125 FAK) and proline-rich
tyrosine kinase 2 (PYK2/CAKb) in cerebral metastases, correlation
with VEGF-R-, ecNOS III-labelling and morphometric data. Anticancer
Res. 20:1419–1424. 2000.PubMed/NCBI
|
